Pharma & Biotech

TG Therapeutics is demonstrating extraordinary momentum, largely driven by the remarkable performance of its flagship therapy. While numerous pharmaceutical companies...

While Eli Lilly continues to dominate headlines with its blockbuster GLP-1 portfolio, a significant development is emerging from its oncology...

Genomics leader Illumina finds itself navigating a complex strategic landscape. The company's latest quarterly results reveal continued revenue pressure, even...

Sellas Life Sciences is generating significant attention with two advanced cancer therapies showing compelling clinical results. The biotechnology firm's innovative...

After an extended period of decline, Baxter International Inc. shares have demonstrated a surprising uptick, posting significant gains in the...

Pliant Therapeutics Inc. is facing a severe market downturn as its share price experiences significant erosion. This steep decline comes...

Xtant Medical, a specialist in the medical technology sector, is navigating a complex strategic pivot. The company recently announced record-breaking...

Shares of Aligos Therapeutics Inc experienced a significant rally on Friday, climbing 6.15% to close at $11.40 after reaching an...

The acquisition of Walgreens Boots Alliance by Sycamore Partners has been finalized, marking a significant turning point for the major...

The investment thesis for medical technology firm Cytosorbents hinges on a single, pending regulatory milestone. With its innovative DrugSorb-ATR blood...